VolitionRx Initiates Second Prostate Cancer Pilot Study Assessing Nucleosomics(R) Technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| VolitionRX Limited (NYSE: VNRX) | Delayed: 0.18 -0.01 (5.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.19 | 52 Week High | $5.86 | |||
| Open | $0.19 | 52 Week Low | $3.05 | |||
| Day High | $0.19 | P/E | N/A | |||
| Day Low | $0.18 | EPS | $-0.45 | |||
| Volume | 492,733 | |||||
| VolitionRX Limited (NYSE: VNRX) | Delayed: 0.18 -0.01 (5.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.19 | 52 Week High | $5.86 | |||
| Open | $0.19 | 52 Week Low | $3.05 | |||
| Day High | $0.19 | P/E | N/A | |||
| Day Low | $0.18 | EPS | $-0.45 | |||
| Volume | 492,733 | |||||
